The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins
Abstract
Abstract Lipoprotein lipase (LPL) activity and mass in plasma and their increase after heparin administration were measured in 61 men who had suffered myocardial infarction before the age of 45 years and in 69 population-based age- and sex-matched control subjects without coronary heart disease to study the relations between these parameters in plasma and their correlations with plasma lipoproteins in subjects with a wide range of lipoprotein and LPL levels. There was a relatively large amount of LPL protein compared with LPL activity in preheparin plasma, indicating that the majority of circulating LPL is catalytically inactive. LPL mass and activity in postheparin plasma (postheparin minus preheparin values) were highly correlated, and the calculated mean specific activity (0.35 mU/ng) was in the range expected for catalytically active LPL. Hence, heparin releases mainly active LPL. The four LPL parameters (mass and activity in plasma and their increase after heparin administration) were not related to each other, except for postheparin plasma LPL mass and activity, and they showed different correlations with plasma lipoprotein lipid concentrations. There was a strong positive correlation between LPL mass in preheparin plasma and the HDL cholesterol level as well as weak negative relations to VLDL triglyceride and cholesterol concentrations in the patients. In contrast, preheparin LPL activity showed no correlation with the HDL cholesterol level but weak positive relations to VLDL triglyceride and cholesterol concentrations in the control subjects. Postheparin plasma LPL activity related positively to the HDL cholesterol level and negatively to the VLDL triglyceride concentration in the control subjects. Case subjects differed from control subjects in that they had higher preheparin plasma LPL activity and a tendency toward lower specific activity of postheparin plasma LPL. The different relations of the measured LPL parameters to plasma lipoproteins and the difference in preheparin plasma LPL activity between patients and control subjects might reflect a disturbance of the LPL system in the patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Heparin releases endothelial bound LPL and may reduce TG levels.54”
From Clinical review on triglycerides (2020) · cites this paper as [54]
Citations
Cites
Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor
Trinder, P. (1969) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456326900600108 · Cited by 4,629
A new method for the direct determination of serum cholesterol.
Zlatkis, A., Zak, B., & Boyle, A. J. (1953) · PubMed · Cited by 2,467
A colorimetric method for estimating serum triglycerides
Fletcher, M. J. (1968) · Clinica Chimica Acta · doi:10.1016/0009-8981(68)90041-7 · Cited by 1,133
Flier, J. S., Underhill, L. H., & Eckel, R. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904203201607 · Cited by 970
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
Groot, P. H. E., van Stiphout, W. A. H. J., Krauss, X. H., Jansen, H., van Tol, A., van Ramshorst, E., Chin-On, S., Albert Hofman, D., Cresswell, S. R., & Havekes, L. M. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.653 · Cited by 528
Beisiegel, U., Weber, W., & Bengtsson-Olivecrona, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8342 · Cited by 468
Carlson, K. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.32 · Cited by 420
Patsch, J. R., Prasad, S. C., Gotto, A. M., & Patsch, W. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113078 · Cited by 377
Nonketotic diabetes mellitus: Insulin deficiency or insulin resistance?
Reaven, G. M., Bernstein, R., Davis, B. M., & Olefsky, J. M. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90536-2 · Cited by 356
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261
Research works printed but not linked: 6
- 10.1161/atv91.12.10.1390589 · DOI
- 1976, Clin Sci Mol Med, 50, 249
- 1988, Am J Physiol, 254, G711
- Hamsten A. Studies on Myocardial Infarction at Young Age: Metabolic Haemostatic and Familial Factors in Post-Infarction Patients Below the Age of 45 . Stockholm Sweden: Karolinska Institute; 1986. Thesis.
- 1953, J Lab Clin, 41, 486
- 10.1161/atv91.11.3.2029503 · DOI
Cited by
Sorted by citations
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,029
Clinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
Current knowledge of hypertriglyceridemic pancreatitis
Valdivielso, P., Ramírez-Bueno, A., & Ewald, N. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.08.008 · Cited by 439
Triglyceride lpases and atherosclerosis
Olivecrona, G., & Olivecrona, T. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199510000-00009 · Cited by 237
Self-citation
Metadata
- Authors
- Tornvall, P., Olivecrona, G., Karpe, F., Hamsten, A., & Olivecrona, T.
- Affiliations
- Karolinska Institutet (SE)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1995-08
- Volume
- 15
- Issue
- 8
- Pages
- 1086-1093
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2059234590
- Cited by
- 172
- References
- 55
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 7 · 2019: 6 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 9 · 2013: 6 · 2012: 3
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- lipoprotein lipase, lipoprotein lipase activity, HDL cholesterol, VLDL triglycerides, VLDL cholesterol, serum lipoproteins, myocardial infarction, young men
- MeSH terms
- Adult, Coronary Disease, Heparin, Humans, Lipoprotein Lipase, Lipoproteins, Male, Middle Aged, Myocardial Infarction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review